This is a long-term, multi-center, longitudinal, observational study in children with achondroplasia (ACH). The aim is to study height velocity and comorbidities in children with ACH. This is a natural history study and no study medication will be administered.

• Inclusion Criteria :
  • Legally authorized representative is willing and able to provide written, signed informed consent (with a written assent from the child when appropriate per local requirements)
  • Willing and able to comply with study protocol per investigator judgement
  • Clinical diagnosis of achondroplasia (confirmed by the investigator)
  • Age between 0 to 8 years old at enrollment
  • Able to stand without assistance (if the child is 24 months or older)
• Study end date : 01/06/2024
• Wales-Based Study Contact : please speak to your clinician

Contact details

Glasgow, Liverpool, London  www.clinicaltrials.gov